These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 24606074

  • 21. Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.
    Kim Y, Tian Y, Yang J, Huser V, Jin P, Lambert CG, Park H, You SC, Park RW, Rijnbeek PR, Van Zandt M, Reich C, Vashisht R, Wu Y, Duke J, Hripcsak G, Madigan D, Shah NH, Ryan PB, Schuemie MJ, Suchard MA.
    Sci Rep; 2020 Jul 06; 10(1):11115. PubMed ID: 32632237
    [Abstract] [Full Text] [Related]

  • 22. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.
    Cadarette SM, Solomon DH, Katz JN, Patrick AR, Brookhart MA.
    Osteoporos Int; 2011 Mar 06; 22(3):943-54. PubMed ID: 20532481
    [Abstract] [Full Text] [Related]

  • 23. Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Martín-Merino E, Petersen I, Hawley S, Álvarez-Gutierrez A, Khalid S, Llorente-Garcia A, Delmestri A, Javaid MK, Van Staa TP, Judge A, Cooper C, Prieto-Alhambra D.
    Osteoporos Int; 2018 Feb 06; 29(2):467-478. PubMed ID: 29199359
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.
    Kingkaew P, Maleewong U, Ngarmukos C, Teerawattananon Y.
    Value Health; 2012 Feb 06; 15(1 Suppl):S20-8. PubMed ID: 22265062
    [Abstract] [Full Text] [Related]

  • 27. Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.
    Orimo H, Nakamura T, Fukunaga M, Ohta H, Hosoi T, Uemura Y, Kuroda T, Miyakawa N, Ohashi Y, Shiraki M, A-TOP (Adequate Treatment of Osteoporosis) research group.
    Curr Med Res Opin; 2011 Jun 06; 27(6):1273-84. PubMed ID: 21554143
    [Abstract] [Full Text] [Related]

  • 28. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database.
    Breart G, Cooper C, Meyer O, Speirs C, Deltour N, Reginster JY.
    Osteoporos Int; 2010 Jul 06; 21(7):1181-7. PubMed ID: 19806285
    [Abstract] [Full Text] [Related]

  • 29. Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.
    Pedersen AB, Heide-Jørgensen U, Sørensen HT, Prieto-Alhambra D, Ehrenstein V.
    JAMA Netw Open; 2019 Apr 05; 2(4):e192416. PubMed ID: 31002319
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC, Lu HT, Dusetzina SB, Wu CH.
    J Womens Health (Larchmt); 2016 Jul 05; 25(7):738-46. PubMed ID: 27096405
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fractures in women treated with raloxifene or alendronate: a retrospective database analysis.
    Foster SA, Shi N, Curkendall S, Stock J, Chu BC, Burge R, Diakun DR, Krege JH.
    BMC Womens Health; 2013 Mar 23; 13():15. PubMed ID: 23521803
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Calcitonin nasal spray and increased cancer risk: a population-based nested case-control study.
    Sun LM, Lin MC, Muo CH, Liang JA, Kao CH.
    J Clin Endocrinol Metab; 2014 Nov 23; 99(11):4259-64. PubMed ID: 25144633
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.